{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:42:52Z","timestamp":1791178972359,"version":"4.1.0"},"reference-count":21,"publisher":"Impact Journals, LLC","issue":"26","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2015,9,9]]},"DOI":"10.18632\/oncotarget.3984","type":"journal-article","created":{"date-parts":[[2015,9,15]],"date-time":"2015-09-15T04:47:30Z","timestamp":1442292450000},"page":"23008-23014","source":"Crossref","is-referenced-by-count":27,"title":["Maintenance chemotherapy in children with ALL exerts metronomic-like thrombospondin-1 associated anti-endothelial effect"],"prefix":"10.18632","volume":"6","author":[{"given":"Nicolas","family":"Andre","sequence":"first","affiliation":[{"name":"Service d'H\u00e9matologie et Oncologie P\u00e9diatrique, Centre Hospitalo-Universitaire Timone Enfants, AP-HM, Marseille, France"},{"name":"Aix-Marseille Universit\u00e9, INSERM, CRO2 UMRS-911, Marseille, France"},{"name":"Metronomics Global Health Initiative, Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Cointe","sequence":"additional","affiliation":[{"name":"Aix-Marseille Universit\u00e9 INSERM, Vascular Research Center of Marseille UMRS-1076, Marseille, France"},{"name":"Laboratoire d'H\u00e9matologie, Centre Hospitalo-Universitaire Conception, AP-HM, Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Barlogis","sequence":"additional","affiliation":[{"name":"Service d'H\u00e9matologie et Oncologie P\u00e9diatrique, Centre Hospitalo-Universitaire Timone Enfants, AP-HM, Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Arnaud","sequence":"additional","affiliation":[{"name":"Laboratoire d'H\u00e9matologie, Centre Hospitalo-Universitaire Conception, AP-HM, Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romaric","family":"Lacroix","sequence":"additional","affiliation":[{"name":"Aix-Marseille Universit\u00e9 INSERM, Vascular Research Center of Marseille UMRS-1076, Marseille, France"},{"name":"Laboratoire d'H\u00e9matologie, Centre Hospitalo-Universitaire Conception, AP-HM, Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eddy","family":"Pasquier","sequence":"additional","affiliation":[{"name":"Aix-Marseille Universit\u00e9, INSERM, CRO2 UMRS-911, Marseille, France"},{"name":"Metronomics Global Health Initiative, Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Dignat-George","sequence":"additional","affiliation":[{"name":"Aix-Marseille Universit\u00e9 INSERM, Vascular Research Center of Marseille UMRS-1076, Marseille, France"},{"name":"Laboratoire d'H\u00e9matologie, Centre Hospitalo-Universitaire Conception, AP-HM, Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9rard","family":"Michel","sequence":"additional","affiliation":[{"name":"Service d'H\u00e9matologie et Oncologie P\u00e9diatrique, Centre Hospitalo-Universitaire Timone Enfants, AP-HM, Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Sabatier","sequence":"additional","affiliation":[{"name":"Aix-Marseille Universit\u00e9 INSERM, Vascular Research Center of Marseille UMRS-1076, Marseille, France"},{"name":"Laboratoire d'H\u00e9matologie, Centre Hospitalo-Universitaire Conception, AP-HM, Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2015,5,4]]},"reference":[{"key":"1","first-page":"328","article-title":"Management strategies in acute lymphoblastic leukemia","volume":"25","author":"Poplack","year":"2011","journal-title":"Oncology (Williston Park)"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Pui, Robison, Look. Acute lymphoblastic leukaemia Lancet. 2008; 371:1030\u20131043.","DOI":"10.1016\/S0140-6736(08)60457-2"},{"key":"3","first-page":"23","article-title":"The anti-angiogenic basis of metronomic chemotherapy","volume":"4","author":"Kamen","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"4","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nrclinonc.2014.89","article-title":"Metronomics: towards personalized chemotherapy?","volume":"11","author":"Pasquier","year":"2014","journal-title":"Nat Rev Clin Oncol"},{"key":"5","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1200\/JCO.2000.18.16.2935","article-title":"High-time chemotherapy or high time for low dose","volume":"18","author":"Kamen","year":"2000","journal-title":"J Clin Oncol"},{"key":"6","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/leu.2008.255","article-title":"Increased bone marrow microvascular density in haematological malignancies is associated with differential regulation of angiogenic factors","volume":"23","author":"Ostenstad","year":"2009","journal-title":"Leukemia"},{"key":"7","doi-asserted-by":"crossref","first-page":"12917","DOI":"10.1073\/pnas.2135406100","article-title":"Thrombospondin 1, a mediator of the antiangiogenic effects of low-dose metronomic chemotherapy","volume":"100","author":"Kerbel","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1172\/JCI35180","article-title":"The anticancer immune response: indispensable for therapeutic success?","volume":"118","author":"Kroemer","year":"2008","journal-title":"J Clin Invest"},{"key":"9","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1582-4934.2008.00639.x","article-title":"Circulating endothelial cells, microparticles and progenitors: key players towards the definition of vascular competence","volume":"13","author":"Dignat-George","year":"2009","journal-title":"J Cell Mol Med"},{"key":"10","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1111\/j.1538-7836.2012.04854.x","article-title":"Mobilization of CD34+ KDR+ endothelial progenitor cells predicts target lesion revascularization","volume":"10","author":"Piot","year":"2012","journal-title":"J Thromb Haemost"},{"key":"11","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ccr.2008.08.001","article-title":"Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents","volume":"14","author":"Roodhart","year":"2008","journal-title":"Cancer Cell"},{"key":"12","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.mvr.2010.02.007","article-title":"Circulating endothelial cells as biomarkers in clinical oncology","volume":"79","author":"Bertolini","year":"2010","journal-title":"Microvasc Res"},{"key":"13","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1200\/JCO.2001.19.4.1195","article-title":"Redifining the target: chemotherapeutics as antiangiogenics","volume":"19","author":"Sledge","year":"2001","journal-title":"J Clin Oncol"},{"key":"14","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1053\/j.seminoncol.2014.04.007","article-title":"Pharmacological regulation of platelet factors that influence tumor angiogenesis","volume":"41","author":"Jurasz","year":"2014","journal-title":"Semin Oncol"},{"key":"15","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nrclinonc.2010.82","article-title":"Metronomic chemotherapy: new rationale for new directions","volume":"7","author":"Andr\u00e9","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"key":"16","first-page":"76187","article-title":"Clinical relevance of regulatory T cells monitoring in the peripheral blood of ovarian cancer patients","author":"\u0160p\u00ed\u0161ek","year":"2015","journal-title":"Hum Immunol"},{"key":"17","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.neo.2014.05.011","article-title":"Anti-Bv8 antibody and metronomic gemcitabine improve pancreatic adenocarcinoma treatment outcome following weekly gemcitabine therapy","volume":"16","author":"Shaked","year":"2014","journal-title":"Neoplasia"},{"key":"18","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1538-7836.2006.01794.x","article-title":"Isolation and enumeration of circulating endothelial cells by immunomagnetic isolation: Proposal of a definition and a consensus protocol","volume":"4","author":"Haubitz","year":"2006","journal-title":"J Thromb Haemost"},{"key":"19","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1538-7836.2008.03200.x","article-title":"Standardization of platelet-derived microparticle counting using calibrated beads and a Cytomics FC500 routine flow cytometer : a first step towards multicenter studies ?","volume":"7","author":"Hauchard","year":"2009","journal-title":"J Thromb Haemost"},{"key":"20","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1089\/scd.1.1996.5.213","article-title":"The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering","volume":"5","author":"Chin-Yee","year":"1996","journal-title":"J Hematother"},{"key":"21","first-page":"2759","article-title":"Deficient CD4+CD25High T regulatory Cell Function in Patients with Active Systemic Lupus Erythematosus","volume":"178","author":"Lipsky","year":"2007","journal-title":"J Immunol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.3984","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T13:23:23Z","timestamp":1589376203000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.3984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,4]]},"references-count":21,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2015,9,9]]}},"alternative-id":["3984","26284583"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.3984","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,4]]}}}